Controlled Trial of the 24-Hour Transdermal Nicotine Patch in Conjunction With Cognitive-Behavioural Therapy
The transdermal nicotine system is an adhesive patch that slowly and continuously delivers nicotine into the bloodstream by percutaneous absorption. The transdermal nicotine system has been shown to be effective as an aid to smoking cessation (1). Concurrent behavioural intervention including a relapse prevention component enhances the maintenance of abstinence following smoking cessation (2).
KeywordsPlacebo Depression Nicotine Carbon Monoxide Hyperthyroidism
Unable to display preview. Download preview PDF.
- 1.Abelin, T, Ehrsam, R, Bihler-Reichert, A, Muller, P, Thommen, A, Vesanen, K (1989). Effectiveness of a transdermal nicotine system in smoking cessation studies. Experimental Clinical Pharmacology 11(3):205–214.Google Scholar
- 3.Mattick R P, Baillie A, editors. An outline for approaches to smoking cessation: quality assurance in the treatment drug dependence project. National campaign Against Drug Abuse Monograph,No 19. Canberra: AGPS, 1992.Google Scholar
- 4.Mendelsohn C P, Richmond R L, (1994). The nicotine patch: guidelines for medical practioners. Modern Medicine 37 (3):105–112.Google Scholar